摘要:
This invention relates to multicyclic compounds, pharmaceutical compositions comprising them, and methods of their use in, for example, the treatment of cognitive disorders.
摘要:
A therapeutic agent for nonviral hepatitis which contains as an active ingredient a piperazine compound represented by the following general formula (I) or a pharmaceutically acceptable salt of the compound.
摘要:
A urea derivative or a salt thereof which each is useful as a therapeutic agent for thrombosis. The derivative is represented by the formula (I) [Chemical formula 1] wherein Cy represents an optionally substituted aromatic hydrocarbon group or optionally substituted aromatic heterocyclic group; R1 represents hydrogen or an optionally substituted hydrocarbon group; V represents -C(O)-, -S(O)-, or -S(O)2-; W represents -N(R2)-, -O-, or a bond (R2 represents hydrogen or an optionally substituted hydrocarbon group); X represents optionally substituted alkylene; Y represents -C(O)-, -S(O)-, or -S(O)2-; Z represents a bond, an optionally substituted chain hydrocarbon group, or -N=; ring A represents an optionally substituted nonaromatic nitrogenous heterocycle; ring B represents an optionally substituted nitrogenous heterocycle; and [Chemical formula 2] each independently indicates a single bond or double bond; provided that R1 may be bonded to R2 to form an optionally substituted nonaromatic nitrogenous heterocycle and that R2 may be bonded to a substituent of X to form an optionally substituted nonaromatic nitrogenous heterocycle.
摘要:
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5, n, m and A have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
摘要:
Compounds of formula (I) wherein Ar1 and Q are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the treatment of depression.
摘要:
The present invention provides a urea derivative or a salt thereof, which is useful as a therapeutic agent for thrombosis. The derivative is represented by Formula (I): [Chemical formula I]
wherein Cy is an aromatic hydrocarbon group which may be substituted or an aromatic heterocyclic group which may be substituted; R 1 is a hydrogen atom or a hydrocarbon group which may be substituted; V is -C(O)-, -S(O)-, or -S(O) 2 -; W is -N(R 2 )-, -O-, or a bond (wherein R 2 is a hydrogen atom or a hydrocarbon group which may be substituted); X is alkylene which may be substituted; Y is -C(O)-, -S(O)-, or -S(O) 2 -; Z is a bond, a chain hydrocarbon group which may be substituted, or -N=; ring A is a non-aromatic nitrogen-containing heterocyclic ring which may be substituted; ring B is a nitrogen-containing heterocyclic ring which may be substituted; and [Chemical formula 2] - - - - - - ‾ , - - - - - - ̲ are each independently a single bond or a double bond; provided that R 1 may be bonded to R 2 to form a non-aromatic nitrogen-containing heterocyclic ring and that R 2 may be bonded to a substituent of X to form a non-aromatic nitrogen-containing heterocyclic ring which may be substituted.
摘要:
A thiazoline derivative represented by Formula (I):
wherein R is a cyclic hydrocarbon group which may be substituted, or a heterocyclic group which may be substituted; X is a bond or a divalent chain hydrocarbon group which may be substituted; X' is a bond or -N(R 5 )-; Y is a divalent hydrocarbon group which may be substituted; Y' is a bond or -C(=O)-; ring A is a nitrogen-containing heterocycle which may be substituted; Z 1 and Z 3 are each independently a bond or a divalent chain hydrocarbon group which may be substituted; Z 2 is a bond or -N(R 6 )-; and B is a group represented by the formula:
which is useful as a therapeutic drug for thrombosis, is provided.